Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal

BACKGROUND: The objective of this study was to identify a subgroup of patients with head and neck squamous cell carcinoma (HNSCC) who might be suitable for hypofractionated radiotherapy (RT‐hypo) during the COVID‐19 pandemic. METHODS: HNSCC cases (oropharynx/larynx/hypopharynx) treated with definiti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Huang, Shao Hui, O’Sullivan, Brian, Su, Jie, Ringash, Jolie, Bratman, Scott V., Kim, John, Hosni, Ali, Bayley, Andrew, Cho, John, Giuliani, Meredith, Hope, Andrew, Spreafico, Anna, Hansen, Aaron R., Siu, Lillian L., Gilbert, Ralph, Irish, Jonathan C., Goldstein, David, de Almeida, John, Tong, Li, Xu, Wei, Waldron, John
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300809/
https://ncbi.nlm.nih.gov/pubmed/32478895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32968
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars